Ann Arbor, MI, United States of America

Clarke Taylor

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Odyssey Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clarke Taylor. Retrieved from https://idiyas.com/inventor/clarke-taylor-1eo6qo8o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Clarke Taylor - Innovator in Medical Research

Introduction

Clarke Taylor is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medical research, particularly in the development of inhibitors for RIPK2, a protein involved in various diseases.

Latest Patents

Clarke Taylor holds a patent for "Inhibitors of RIPK2 and medical uses thereof." This patent relates to RIPK2 inhibitors represented by a specific structural formula. The disclosure further includes pharmaceutical compositions comprising these inhibitors and methods for treating conditions such as inflammatory diseases, autoimmune diseases, granulomatous disease, neurodegenerative disease, and cancer. He has 1 patent to his name.

Career Highlights

Clarke Taylor is currently associated with Odyssey Therapeutics, Inc., where he continues to advance his research in the medical field. His work focuses on innovative solutions to combat serious health conditions.

Collaborations

Clarke collaborates with talented individuals such as Chad Vanhuis and Shifeng Pan, contributing to a dynamic research environment.

Conclusion

Clarke Taylor's innovative work in developing RIPK2 inhibitors showcases his commitment to improving medical treatments. His contributions are vital in the ongoing fight against various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…